Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Bliss GVS Pharma Annual General Meeting

Bliss GVS Pharma concluded its 41st AGM on July 15, 2026. Shareholders approved a 100% final dividend of Re. 1.00 per share for FY 2025-26.

Source

BSE filing, NSE: BLISSGVS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bliss GVS Pharma Ltd: key numbers

Share price
₹648.50
Market cap
₹6,899 Cr
Revenue (annual)
₹927.1 Cr
Net profit (annual)
₹129.1 Cr
P/E (TTM)
50.7×Sector 46.1×
Promoter holding
50.07%+15.06% QoQ
FII holding
5.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bliss GVS Pharma Ltd

All →

Other annual general meeting announcements

All →